Loading…
Bio Green Med Solution, Inc. is projected to rise to $1.03 by 2027, a +7% move from its current price of $0.96. BGMS is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $0.9214 | $0.9592 | $0.9985 | -0.09% |
| May 30 | $0.9054 | $0.9583 | $1.01 | -0.17% |
| May 31 | $0.8931 | $0.9575 | $1.03 | -0.26% |
| Jun 1 | $0.8828 | $0.9566 | $1.04 | -0.35% |
| Jun 2 | $0.8737 | $0.9558 | $1.05 | -0.44% |
| Jun 3 | $0.8655 | $0.955 | $1.05 | -0.52% |
| Jun 4 | $0.8579 | $0.9541 | $1.06 | -0.61% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.8579 | $0.9541 | $1.06 | -0.61% |
| Week 2 | $0.816 | $0.9483 | $1.10 | -1.22% |
| Week 3 | $0.7841 | $0.9425 | $1.13 | -1.82% |
| Week 4 | $0.7574 | $0.9367 | $1.16 | -2.42% |
| Week 5 | $0.7341 | $0.931 | $1.18 | -3.02% |
| Week 6 | $0.7133 | $0.9253 | $1.20 | -3.61% |
| Week 7 | $0.6943 | $0.9197 | $1.22 | -4.20% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Bio Green Med Solution, Inc. engages in the distributing, trading, and installation of protective and fire safety materials and equipment, and fire protection and prevention systems. It is also involved in research and development of pharmaceuticals.
The company was formerly known as Cyclacel Pharmaceuticals, Inc. and changed its name to Bio Green Med Solution, Inc. in September 2022. Bio Green Med Solution, Inc. was founded in 1996 and is headquartered in Kuala Lumpur, Malaysia.
It is categorized in Healthcare and operates across safety materials, systems installation, and pharmaceutical R&D. These activities place the company in the Healthcare sector with a focus on protective safety solutions and ongoing pharmaceutical research.
The BGMS ticker symbol and current corporate identity reflect a transition from Cyclacel Pharmaceuticals to Bio Green Med Solution, Inc., with its roots in a 1996 founding and a Kuala Lumpur address anchoring its corporate presence.
Bio Green Med Solution, Inc. (BGMS) is a healthcare company represented by the symbol BGMS. The current price is $0.97 and the market cap is $5.35M, with a rank of 5325.
The price outlook is informed by a year-by-year forecast that shows the average price rising from $0.97 in 2026 to $2.86 by 2050, with a maximum forecast of $6.41 in 2050. This trajectory suggests meaningful upside in the long run, anchored by higher-end forecast scenarios in later years.
Forecast sentiment shifts from NEUTRAL in 2026 and 2027 to BULLISH from 2028 onward, culminating in a BULLISH stance in 2050. The path implies a gradual transition from a stable near-term outlook to stronger upside potential over the multi-year horizon.
A major floor 27.1% below — a decisive break under it would weaken the trend.
The nearest floor, 8.3% below — buyers have tended to step in here.
The nearest ceiling, 24.0% above — a clean break opens room to run.
A major ceiling 66.7% above — clearing it would confirm fresh momentum.
Key BGMS support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of BGMS market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.97 | Sell | $0.9689 | Sell |
| MA 10 | $0.983 | Sell | $0.9727 | Sell |
| MA 20 | $0.974 | Sell | $0.9802 | Sell |
| MA 50 | $0.9968 | Sell | $1.02 | Sell |
| MA 100 | $1.07 | Sell | $1.83 | Sell |
| MA 200 | $2.47 | Sell | $17.48 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 46.63 | Neutral |
| Stoch RSI (14) | 52.34 | Neutral |
| CCI (20) | -30.70 | Neutral |
| Williams %R (14) | -52.94 | Info |
| MACD (12,26,9) | 0.00 | Buy |
| ROC (12) | 9.09 | Buy |
| Bollinger %B (20,2) | 0.41 | Neutral |
| Stochastic %K (14) | 47.06 | Neutral |
| TRIX (15) | -0.15 | Sell |
| Awesome (5,34) | -0.03 | Sell |
| Ultimate (7,14,28) | 36.64 | Neutral |
| Momentum (10) | 0.02 | Buy |
| Aroon Osc (25) | -48.00 | Sell |
| Hull MA (9) | 0.97 | Sell |
| ADX (14) | 8.89 | Neutral |
| ATR (14) | 0.03 | Info |
The 30-day technical picture is NEUTRAL, with RSI14 at 50. This indicates balanced momentum in the near term.
Near-term moving averages show SMA50 at $0.9932 and SMA200 at $2.55, suggesting a closer anchor near the $1 level while longer-term averages sit higher. Support is at $0.88 and resistance at $1.19, framing a modest trading band.
The 30-day range spans from $0.7323 to $1.28, illustrating a relatively tight window around the $1 level. Annualized volatility sits at 80%, underscoring elevated price variability over a yearly horizon.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.83 | $0.96 | $1.21 | 0% | Neutral | |
| $0.7796 | $1.03 | $1.46 | +7% | Neutral | |
| $0.8501 | $1.17 | $1.75 | +22% | Bullish | |
| $0.8928 | $1.28 | $1.97 | +33% | Bullish | |
| $0.8304 | $1.22 | $1.96 | +28% | Bullish | |
| $0.6926 | $1.05 | $1.73 | +10% | Neutral | |
| $0.7107 | $1.11 | $1.87 | +16% | Neutral | |
| $0.7383 | $1.18 | $2.04 | +23% | Bullish | |
| $0.866 | $1.43 | $2.51 | +49% | Bullish | |
| $0.971 | $1.64 | $2.94 | +71% | Bullish | |
| $0.9551 | $1.81 | $3.51 | +88% | Bullish | |
| $1.29 | $2.86 | $6.22 | +198% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $0.83 | $0.96 | $1.13 | +0.00% |
| June 2026 | $0.752 | $0.8923 | $1.09 | -7.06% |
| July 2026 | $0.7377 | $0.8863 | $1.10 | -0.67% |
| August 2026 | $0.7663 | $0.9298 | $1.18 | +4.91% |
| September 2026 | $0.7461 | $0.9127 | $1.17 | -1.85% |
| October 2026 | $0.7112 | $0.8766 | $1.13 | -3.95% |
| November 2026 | $0.7292 | $0.9048 | $1.18 | +3.21% |
| December 2026 | $0.7347 | $0.9174 | $1.21 | +1.40% |
Click any year to see its month-by-month BGMS forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The BGMS price prediction for 2026 points to an average of $0.96 (low $0.83, high $1.21) — a potential gain of 0% on today's $0.96. Price action looks broadly range-bound.
In 2027, BGMS is projected to trade between $0.7796 and $1.46, averaging $1.03 — a potential gain of +7% from today's $0.96. That is up +7% on the projected 2026 average. A consolidation phase looks the most probable path here.
Bio Green Med Solution, Inc.'s 2028 outlook centres on $1.17, within a $0.8501 to $1.75 range. That is up +14% on the projected 2027 average. That marks a +22% change versus current levels. Momentum favours further upside here.
By 2029, BGMS could reach as high as $1.97, with a base case around $1.28 and support toward $0.8928 — roughly +33% from $0.96. Buyers look set to stay in control over this stretch.
Expect BGMS to range from $0.8304 to $1.96 through 2030. The $1.22 average target implies a +28% move from current prices. That is -4% versus the projected 2029 average. Momentum favours further upside here.
The BGMS price prediction for 2031 points to an average of $1.05 (low $0.6926, high $1.73) — a potential gain of +10% on today's $0.96. A consolidation phase looks the most probable path here.
In 2032, BGMS is projected to trade between $0.7107 and $1.87, averaging $1.11 — a potential gain of +16% from today's $0.96. That is up +6% on the projected 2031 average. Price action looks broadly range-bound.
Bio Green Med Solution, Inc.'s 2033 outlook centres on $1.18, within a $0.7383 to $2.04 range. That is up +7% on the projected 2032 average. That marks a +23% change versus current levels. Buyers look set to stay in control over this stretch.
By 2034, BGMS could reach as high as $2.51, with a base case around $1.43 and support toward $0.866 — roughly +49% from $0.96. Momentum favours further upside here.
Expect BGMS to range from $0.971 to $2.94 through 2035. The $1.64 average target implies a +71% move from current prices. That is up +15% on the projected 2034 average. Buyers look set to stay in control over this stretch.
The BGMS price prediction for 2040 points to an average of $1.81 (low $0.9551, high $3.51) — a potential gain of +88% on today's $0.96. Momentum favours further upside here.
In 2050, BGMS is projected to trade between $1.29 and $6.22, averaging $2.86 — a potential gain of +198% from today's $0.96. That is up +58% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in BGMS today (≈ 1,041.666667 BGMS) could be worth
$2,977.94
+$1,977.94 (+198%) by 2050 · US Dollar
Based on the average projected BGMS price of $2.86 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in BGMSwould be worth at today's price.
$1,000 invested in BGMS on May 27, 2025 (≈ 41.152265 BGMS) would be worth
$39.51
-$960.49 (-96.0%) today · 0.04× · US Dollar
Based on a BGMS entry price of $24.3 vs. today's $0.96.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.96 | $1,000 | +0.0% |
| 1 month ago | $0.97 | $989.69 | -1.0% |
| 3 months ago | $1.01 | $950.5 | -5.0% |
| 6 months ago | $1.51 | $635.76 | -36.4% |
| 1 year ago | $24.3 | $39.51 | -96.0% |
| All time (5.0y) ago | $26,280 | $0.04 | -100.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our BGMS forecast.
Our base-case forecast reaches $1.90 around 2050.
Implied market cap at $1.90: $10.49M
The multi-year forecast highlights a progression toward higher average prices and upside potential. For 2026, the avg is $0.97 with a min of $0.83 and a max of $1.22, and ROI is 0 with NEUTRAL sentiment. In 2027 the avg rises to $1.04 with ROI 7 and NEUTRAL sentiment, while 2028 shows $1.21 (ROI 24.7) and a BULLISH stance.
By 2029 the avg is $1.30 with ROI 33.9 and BULLISH sentiment, and 2030 projects an avg of $1.24 with ROI 27.9 and BULLISH sentiment. The forecast continues with 2031 at $1.07 (ROI 10, NEUTRAL), 2032 at $1.11 (ROI 14.8, NEUTRAL), and 2033 at $1.20 (ROI 23.7, BULLISH).
The longer horizon shows stronger upside: 2034 avg $1.46 (ROI 50.9, BULLISH), 2035 avg $1.67 (ROI 71.9, BULLISH), 2040 avg $1.86 (ROI 91.9, BULLISH), and 2050 avg $2.86 (ROI 195.1, BULLISH). These figures illustrate a bullish tilt in later years with substantial upside in the far horizon, while acknowledging uncertainty inherent to price forecasts.
Tap a question to reveal the answer.
The 2030 forecast shows a min of $0.8259, an avg of $1.24, and a max of $2.02, with an ROI of 27.9 and a BULLISH sentiment.
The year-by-year forecast includes positive ROI in multiple years: 2027 shows 7, 2028 24.7, 2029 33.9, 2030 27.9, 2031 10, 2032 14.8, 2033 23.7, 2034 50.9, 2035 71.9, 2040 91.9, and 2050 195.1. Sentiment shifts from NEUTRAL in 2026–2027 to BULLISH from 2028 onward.
Yes, the maximum forecast for 2050 is $6.41 with an ROI of 195.1 and a BULLISH sentiment.
Current price is $0.97 and the market cap is $5.35M.
The 30-day picture is NEUTRAL with RSI14 at 50. The SMA50 is $0.9932 and the SMA200 is $2.55. Support is $0.88 and resistance is $1.19. The 30-day range is $0.7323 to $1.28, and annualized volatility is 80%.
Bio Green Med Solution, Inc. Community Discussion
0Share your Bio Green Med Solution, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.